Dara Biosciences
Pharmaceutical Manufacturing11-50 Employees
DARA is a specialty Pharmaceutical Company focused on the development and commercialization of oncology treatment and supportive care. DARA holds the exclusive U.S. marketing rights to Soltamox®, a novel oral liquid formulation of tamoxifen citrate, a product used widely in the treatment and prevention of breast cancer. Soltamox is the only FDA approved oral liquid version of tamoxifen citrate and fulfills a vital clinical need for patients who cannot tolerate existing tablet formulations of this drug. DARA has also obtained exclusive U.S. commercial rights for Bionect® (hyaluronic acid sodium salt, 0.2%) within the oncology and radiation oncology marketplace. Bionect is an FDA-cleared product indicated for the management of irritation of the skin.
1-888-653-2347 
support@leadiq.com 
